ArticleFrontiers in microbiology2022
Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Genomics of multidrug-resistantIJID regions · 2026Article
- Global Genomic Analysis of Bovine-AssociatedBiology · 2026Article
- Quantitative Multiplex Digital PCR with Fluorescence-Encoded Nanoreactor Beads.Analytical chemistry · 2026Article
- First report of carbapenemase-producing bacteria from poultry farms in the United Arab Emirates: an emerging One Health threat.Frontiers in veterinary science · 2026Article
- High-risk extended-spectrum β-lactamase-producing Klebsiella pneumoniae ST307 in a neonatal sepsis outbreak in Zambia: a secondary genomic analysis.Access microbiology · 2026Article
- Plasmid-resolved genomics and machine learning-assisted profiling revealFrontiers in microbiology · 2026Article
- Coexistence of aInfection and drug resistance · 2026Article
- Cross-species transmission ofFrontiers in cellular and infection microbiology · 2026Review
- Wildlife as sentinel of antimicrobial resistance inFrontiers in microbiology · 2026Article
- Plasmid genomic epidemiology ofMicrobial genomics · 2025Article
- Nationwide surveillance of carbapenem-resistant Gram-negative pathogens in the Lebanese environment.Applied and environmental microbiology · 2025Article
- Hybrid Genome and Clinical Impact of Emerging Extensively Drug-Resistant Priority Bacterial PathogenLife (Basel, Switzerland) · 2025Article
- Plasmid diversity ofMicrobiology spectrum · 2025Article
- Genomic characterization of plasmids harboringMicrobiology spectrum · 2025Article
- First Report in the Americas ofAntibiotics (Basel, Switzerland) · 2025Article
- Detection of KPC-producing Enterobacterales species in wastewater samples from the Gran Concepción Metropolitan area, Chile.Biological research · 2025Article
- Genomic Insights into Bacterial Antimicrobial Resistance Transmission and Mitigation Strategies.Current pharmaceutical biotechnology · 2025Review
- Molecular Characterization of Multidrug-Resistant and Hypervirulent New Delhi Metallo-Beta-LactamaseAntibiotics (Basel, Switzerland) · 2024Article
- Carbapenem-resistantJAC-antimicrobial resistance · 2024Article
- Genomic insights into the evolution and mechanisms of carbapenem-resistant hypervirulent Klebsiella pneumoniae co-harboring blaAnnals of clinical microbiology and antimicrobials · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.